{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T02:21:54Z","timestamp":1789611714826,"version":"build-2803163510"},"reference-count":104,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1053\/j.ajkd.2014.12.016","type":"journal-article","created":{"date-parts":[[2015,2,26]],"date-time":"2015-02-26T11:17:21Z","timestamp":1424949441000},"page":"196-205","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Cardiorenal Syndrome and the Role of the Bone-Mineral Axis\u00a0and\u00a0Anemia"],"prefix":"10.1053","volume":"66","author":[{"given":"David M.","family":"Charytan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Fishbane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Malyszko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"McCullough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Goldsmith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1053\/j.ajkd.2014.12.016_bib1","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1093\/ndt\/gfq136","article-title":"Definition and classification of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference","volume":"25","author":"House","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2014.12.016_bib2","unstructured":"Minino AM. Death in the United States, 2011. NCHS data brief, no 115. Hyattsville, MD; 2013. http:\/\/www.cdc.gov\/nchs\/data\/databriefs\/db115.htm. Accessed November 6,\u00a02013."},{"key":"10.1053\/j.ajkd.2014.12.016_bib3","first-page":"1","article-title":"Deaths: preliminary data for 2011","volume":"61","author":"Hoyert","year":"2012","journal-title":"Natl Vital Stat Rep"},{"issue":"17","key":"10.1053\/j.ajkd.2014.12.016_bib4","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1161\/01.CIR.0000095676.90936.80","article-title":"Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention","volume":"108","author":"Sarnak","year":"2003","journal-title":"Circulation"},{"issue":"13","key":"10.1053\/j.ajkd.2014.12.016_bib5","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1056\/NEJMoa041365","article-title":"Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction","volume":"351","author":"Anavekar","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"13","key":"10.1053\/j.ajkd.2014.12.016_bib6","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"1 suppl 1","key":"10.1053\/j.ajkd.2014.12.016_bib7","first-page":"e1","article-title":"US Renal Data System 2013 annual data report","volume":"63","author":"Collins","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2014.12.016_bib8","unstructured":"Centers for Disease Control and Prevention. National Chronic Kidney Disease Fact Sheet: general information and national estimates on chronic kidney disease in the United States, 2010. Atlanta, GA; 2010. http:\/\/www.cdc.gov\/diabetes\/pubs\/pdf\/kidney_factsheet.pdf. Accessed November 6,\u00a02013."},{"issue":"1","key":"10.1053\/j.ajkd.2014.12.016_bib9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11892-010-0162-y","article-title":"Cardiovascular disease in chronic kidney disease: data from the Kidney Early Evaluation Program (KEEP)","volume":"11","author":"McCullough","year":"2011","journal-title":"Curr Diab Rep"},{"issue":"13","key":"10.1053\/j.ajkd.2014.12.016_bib10","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJM197403282901301","article-title":"Accelerated atherosclerosis in prolonged maintenance hemodialysis","volume":"290","author":"Lindner","year":"1974","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1053\/j.ajkd.2014.12.016_bib11","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1681\/ASN.2004080656","article-title":"Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the Atherosclerosis Risk in Communities Study","volume":"16","author":"Muntner","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2014.12.016_bib12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.7326\/0003-4819-140-1-200401060-00006","article-title":"The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease","volume":"140","author":"Muntner","year":"2004","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1053\/j.ajkd.2014.12.016_bib13","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.amjmed.2012.08.018","article-title":"Phosphorus and risk of renal failure in subjects with normal renal function","volume":"126","author":"Sim","year":"2013","journal-title":"Am J Med"},{"issue":"12","key":"10.1053\/j.ajkd.2014.12.016_bib14","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1097\/01.ASN.0000100127.54107.57","article-title":"Association of comorbid conditions and mortality in hemodialysis patients in Europe, Japan, and the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"14","author":"Goodkin","year":"2003","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"8","key":"10.1053\/j.ajkd.2014.12.016_bib15","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.2215\/CJN.00070109","article-title":"Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function","volume":"4","author":"Lash","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"10.1053\/j.ajkd.2014.12.016_bib16","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/eurheartj\/eht386","article-title":"Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis","volume":"35","author":"Damman","year":"2014","journal-title":"Eur Heart J"},{"issue":"23","key":"10.1053\/j.ajkd.2014.12.016_bib17","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1161\/CIRCULATIONAHA.109.886473","article-title":"Cardiorenal syndrome: new perspectives","volume":"121","author":"Bock","year":"2010","journal-title":"Circulation"},{"issue":"3-4","key":"10.1053\/j.ajkd.2014.12.016_bib18","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000353593","article-title":"The role of fibroblast growth factor-23 in cardiorenal syndrome","volume":"123","author":"Kovesdy","year":"2013","journal-title":"Nephron Clin Pract"},{"key":"10.1053\/j.ajkd.2014.12.016_bib19","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1138\/20100479","article-title":"Chronic kidney disease-mineral bone disorder (CKD-MBD)","volume":"7","author":"Kiattisunthorn","year":"2010","journal-title":"IBMS BoneKey"},{"key":"10.1053\/j.ajkd.2014.12.016_bib20","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1146\/annurev.med.57.121304.131310","article-title":"Hemochromatosis: genetics and pathophysiology","volume":"57","author":"Beutler","year":"2006","journal-title":"Annu Rev Med"},{"issue":"4","key":"10.1053\/j.ajkd.2014.12.016_bib21","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/j.ajkd.2009.12.030","article-title":"Molecular mechanisms of hepcidin regulation: implications for the anemia of CKD","volume":"55","author":"Babitt","year":"2010","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.ajkd.2014.12.016_bib22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000098522","article-title":"Hepcidin in anemia and inflammation in chronic kidney disease","volume":"30","author":"Malyszko","year":"2007","journal-title":"Kidney Blood Press Res"},{"issue":"1","key":"10.1053\/j.ajkd.2014.12.016_bib23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/ncpneph0655","article-title":"Mechanisms of disease: erythropoietin resistance in patients with both heart and kidney failure","volume":"4","author":"van der Putten","year":"2008","journal-title":"Nat Clin Pract Nephrol"},{"issue":"9","key":"10.1053\/j.ajkd.2014.12.016_bib24","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/eurjhf\/hfq099","article-title":"Hepcidin-25 is a marker of the response rather than resistance to exogenous erythropoietin in chronic kidney disease\/chronic heart failure patients","volume":"12","author":"van der Putten","year":"2010","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"10.1053\/j.ajkd.2014.12.016_bib25","doi-asserted-by":"crossref","first-page":"e9246","DOI":"10.1371\/journal.pone.0009246","article-title":"Soluble erythropoietin receptor contributes to erythropoietin resistance in end-stage renal disease","volume":"5","author":"Khankin","year":"2010","journal-title":"PLoS One"},{"issue":"4","key":"10.1053\/j.ajkd.2014.12.016_bib26","doi-asserted-by":"crossref","first-page":"c373","DOI":"10.1159\/000321521","article-title":"Serum 25(OH)-cholecalciferol concentration is associated with hemoglobin level and erythropoietin resistance in patients on maintenance hemodialysis","volume":"117","author":"Kiss","year":"2011","journal-title":"Nephron Clin Pract"},{"issue":"7","key":"10.1053\/j.ajkd.2014.12.016_bib27","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.2215\/CJN.00380111","article-title":"Endogenous erythropoietin and the association with inflammation and mortality in diabetic chronic kidney disease","volume":"6","author":"Wagner","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1053\/j.ajkd.2014.12.016_bib28","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/ajh.2830460422","article-title":"Cefotetan-induced hemolytic anemia causing severe hypophosphatemia","volume":"46","author":"Mohammed","year":"1994","journal-title":"Am J Hematol"},{"issue":"9","key":"10.1053\/j.ajkd.2014.12.016_bib29","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/sj.bmt.1702407","article-title":"Severe hypophosphatemia during hematopoietic reconstitution after allogeneic peripheral blood stem cell transplantation","volume":"25","author":"Steiner","year":"2000","journal-title":"Bone Marrow Transplant"},{"issue":"12","key":"10.1053\/j.ajkd.2014.12.016_bib30","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1111\/j.1537-2995.2009.02327.x","article-title":"Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial","volume":"49","author":"Van Wyck","year":"2009","journal-title":"Transfusion"},{"issue":"1","key":"10.1053\/j.ajkd.2014.12.016_bib31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.lab.2005.02.015","article-title":"Effect of saccharated ferric oxide and iron dextran on the metabolism of phosphorus in rats","volume":"146","author":"Sanai","year":"2005","journal-title":"J\u00a0Lab Clin Med"},{"issue":"4","key":"10.1053\/j.ajkd.2014.12.016_bib32","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.bone.2009.06.017","article-title":"Hypophosphatemia induced by intravenous administration of saccharated ferric oxide: another form of FGF23-related hypophosphatemia","volume":"45","author":"Shimizu","year":"2009","journal-title":"Bone"},{"issue":"7","key":"10.1053\/j.ajkd.2014.12.016_bib33","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1210\/jc.2008-2396","article-title":"FGF23 elevation and hypophosphatemia after intravenous iron polymaltose: a prospective study","volume":"94","author":"Schouten","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1053\/j.ajkd.2014.12.016_bib34","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/1471-2369-14-167","article-title":"Effect of ferric carboxymaltose on serum phosphate and C-terminal FGF23 levels in non-dialysis chronic kidney disease patients: post-hoc analysis of a prospective study","volume":"14","author":"Prats","year":"2013","journal-title":"BMC Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2014.12.016_bib35","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s10157-012-0725-0","article-title":"The effects of iron on FGF23-mediated Ca-P metabolism in CKD patients","volume":"17","author":"Deger","year":"2013","journal-title":"Clin Exp Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2014.12.016_bib36","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1159\/000327019","article-title":"Effect of intravenous saccharated ferric oxide on serum FGF23 and mineral metabolism in hemodialysis patients","volume":"33","author":"Takeda","year":"2011","journal-title":"Am J Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2014.12.016_bib37","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1681\/ASN.2013040355","article-title":"Suppression of iron-regulatory hepcidin by vitamin D","volume":"25","author":"Bacchetta","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2014.12.016_bib38","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/cvr\/cvs240","article-title":"Effects of phosphate on vascular function under normal conditions and influence of the uraemic state","volume":"96","author":"Six","year":"2012","journal-title":"Cardiovasc Res"},{"issue":"2","key":"10.1053\/j.ajkd.2014.12.016_bib39","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/ki.2012.300","article-title":"High phosphate directly affects endothelial function by downregulating annexin II","volume":"83","author":"Di Marco","year":"2013","journal-title":"Kidney Int"},{"issue":"11","key":"10.1053\/j.ajkd.2014.12.016_bib40","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nrneph.2013.111","article-title":"Klotho, phosphate and FGF-23 in ageing and disturbed mineral metabolism","volume":"9","author":"Kuro","year":"2013","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"10.1053\/j.ajkd.2014.12.016_bib41","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1681\/ASN.2009060640","article-title":"Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification","volume":"21","author":"Shroff","year":"2010","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"2","key":"10.1053\/j.ajkd.2014.12.016_bib42","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000197562","article-title":"Phosphate\u2014the silent stealthy cardiorenal culprit in all stages of chronic kidney disease: a systematic review","volume":"27","author":"Kanbay","year":"2009","journal-title":"Blood Purif"},{"issue":"2","key":"10.1053\/j.ajkd.2014.12.016_bib43","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10741-011-9232-8","article-title":"Mineral metabolism abnormalities and vitamin D receptor activation in cardiorenal syndromes","volume":"17","author":"Ronco","year":"2012","journal-title":"Heart Fail Rev"},{"issue":"8","key":"10.1053\/j.ajkd.2014.12.016_bib44","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.3390\/nu5083005","article-title":"Vitamin D and cardiovascular disease","volume":"5","author":"Kienreich","year":"2013","journal-title":"Nutrients"},{"issue":"6","key":"10.1053\/j.ajkd.2014.12.016_bib45","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1111\/j.1523-1755.2004.66013.x","article-title":"Adverse effects of hyperphosphatemia on myocardial hypertrophy, renal function, and bone in rats with renal failure","volume":"66","author":"Neves","year":"2004","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.ajkd.2014.12.016_bib46","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/ndt\/gfr447","article-title":"Parathyroid hormone and phosphorus overload in uremia: impact on cardiovascular system","volume":"27","author":"Custodio","year":"2012","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"10.1053\/j.ajkd.2014.12.016_bib47","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1681\/ASN.2005040365","article-title":"Myocardial stiffness, cardiac remodeling, and diastolic dysfunction in calcification-prone fetuin-A-deficient mice","volume":"16","author":"Merx","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1-2","key":"10.1053\/j.ajkd.2014.12.016_bib48","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.clinbiochem.2013.09.012","article-title":"Product of serum calcium and phosphorus (Ca x PO4) as predictor of cardiovascular disease risk in predialysis patients","volume":"47","author":"Regmi","year":"2014","journal-title":"Clin Biochem"},{"issue":"4","key":"10.1053\/j.ajkd.2014.12.016_bib49","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","article-title":"Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study","volume":"31","author":"Block","year":"1998","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"10.1053\/j.ajkd.2014.12.016_bib50","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.ajkd.2014.12.016_bib51","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1093\/ndt\/gfn613","article-title":"Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease","volume":"24","author":"Covic","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"10.1053\/j.ajkd.2014.12.016_bib52","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J\u00a0Clin Invest"},{"issue":"11","key":"10.1053\/j.ajkd.2014.12.016_bib53","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1093\/ndt\/gft268","article-title":"Vitamin D receptor activation, left ventricular hypertrophy and myocardial fibrosis","volume":"28","author":"Panizo","year":"2013","journal-title":"Nephrol Dial Transplant"},{"issue":"3-5","key":"10.1053\/j.ajkd.2014.12.016_bib54","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jsbmb.2006.12.081","article-title":"Heart extracellular matrix gene expression profile in the vitamin D receptor knockout mice","volume":"103","author":"Rahman","year":"2007","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"issue":"3-5","key":"10.1053\/j.ajkd.2014.12.016_bib55","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jsbmb.2006.12.098","article-title":"Characterization of heart size and blood pressure in the vitamin D receptor knockout mouse","volume":"103","author":"Simpson","year":"2007","journal-title":"J\u00a0Steroid Biochem Mol Biol"},{"issue":"4","key":"10.1053\/j.ajkd.2014.12.016_bib56","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1097\/01.ASN.0000056188.23717.E5","article-title":"Beneficial effects of calcimimetics on progression of renal failure and cardiovascular risk factors","volume":"14","author":"Ogata","year":"2003","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"10","key":"10.1053\/j.ajkd.2014.12.016_bib57","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1681\/ASN.V4101814","article-title":"A\u00a0role of parathyroid hormone for the activation of cardiac fibroblasts in uremia","volume":"4","author":"Amann","year":"1994","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2014.12.016_bib58","doi-asserted-by":"crossref","first-page":"p112","DOI":"10.1159\/000092244","article-title":"Effect of parathyroidectomy on cardiac fibrosis and apoptosis: possible role of aldosterone","volume":"103","author":"Rodriguez-Ayala","year":"2006","journal-title":"Nephron Physiol"},{"issue":"9","key":"10.1053\/j.ajkd.2014.12.016_bib59","doi-asserted-by":"crossref","first-page":"e44161","DOI":"10.1371\/journal.pone.0044161","article-title":"A\u00a0comparative transcriptome analysis identifying FGF23 regulated genes in the kidney of a mouse CKD model","volume":"7","author":"Dai","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1053\/j.ajkd.2014.12.016_bib60","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s00246-012-0489-z","article-title":"Vitamin D deficiency is associated with increased left ventricular mass and diastolic dysfunction in children with chronic kidney disease","volume":"34","author":"Patange","year":"2013","journal-title":"Pediatr Cardiol"},{"issue":"3","key":"10.1053\/j.ajkd.2014.12.016_bib61","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.amjcard.2012.10.021","article-title":"Relation of vitamin D and parathyroid hormone to cardiac biomarkers and to left ventricular mass (from the Cardiovascular Health Study)","volume":"111","author":"van Ballegooijen","year":"2013","journal-title":"Am J Cardiol"},{"issue":"14","key":"10.1053\/j.ajkd.2014.12.016_bib62","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.jacc.2011.03.069","article-title":"Vitamin D, parathyroid hormone, and cardiovascular events among older adults","volume":"58","author":"Kestenbaum","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"19","key":"10.1053\/j.ajkd.2014.12.016_bib63","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","article-title":"Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease","volume":"119","author":"Gutierrez","year":"2009","journal-title":"Circulation"},{"issue":"1","key":"10.1053\/j.ajkd.2014.12.016_bib64","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000339026","article-title":"Relationship of fibroblast growth factor 23 with left ventricle mass index and coronary calcificaton in chronic renal disease","volume":"36","author":"Unsal","year":"2012","journal-title":"Kidney Blood Press Res"},{"issue":"2","key":"10.1053\/j.ajkd.2014.12.016_bib65","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1681\/ASN.2013050465","article-title":"Fibroblast growth factor-23 and cardiovascular events in CKD","volume":"25","author":"Scialla","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"10","key":"10.1053\/j.ajkd.2014.12.016_bib66","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jacc.2008.04.061","article-title":"Anemia and mortality in heart failure patients a systematic review and meta-analysis","volume":"52","author":"Groenveld","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1053\/j.ajkd.2014.12.016_bib67","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0272-6386(96)90130-4","article-title":"The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease","volume":"28","author":"Foley","year":"1996","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.ajkd.2014.12.016_bib68","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0272-6386(99)70118-6","article-title":"Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin","volume":"34","author":"Levin","year":"1999","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1053\/j.ajkd.2014.12.016_bib69","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/S0735-1097(02)01854-5","article-title":"Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure","volume":"39","author":"Horwich","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"10","key":"10.1053\/j.ajkd.2014.12.016_bib70","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1093\/eurjhf\/hft083","article-title":"Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status","volume":"15","author":"Comin-Colet","year":"2013","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"10.1053\/j.ajkd.2014.12.016_bib71","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1042\/cs0910233","article-title":"Experimental iron deficiency in rats: mechanical and electrophysiological alterations in the cardiac muscle","volume":"91","author":"Goldstein","year":"1996","journal-title":"Clin Sci (Lond)"},{"issue":"3","key":"10.1053\/j.ajkd.2014.12.016_bib72","doi-asserted-by":"crossref","first-page":"H1407","DOI":"10.1152\/ajpheart.2001.280.3.H1407","article-title":"Effect of anemia on cardiac function, microvascular structure, and capillary hematocrit in rat\u00a0hearts","volume":"280","author":"Rakusan","year":"2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"10.1053\/j.ajkd.2014.12.016_bib73","first-page":"227","article-title":"Myocyte cellular hypertrophy and hyperplasia contribute to ventricular wall remodeling in anemia-induced cardiac hypertrophy in rats","volume":"141","author":"Olivetti","year":"1992","journal-title":"Am J Pathol"},{"issue":"6","key":"10.1053\/j.ajkd.2014.12.016_bib74","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/0735-1097(95)00007-Q","article-title":"Endothelium-derived relaxing factor is important in mediating the high output state in chronic severe anemia","volume":"25","author":"Anand","year":"1995","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1053\/j.ajkd.2014.12.016_bib75","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1136\/hrt.70.4.357","article-title":"Pathogenesis of oedema in chronic severe anaemia: studies of body water and sodium, renal function, haemodynamic variables, and plasma hormones","volume":"70","author":"Anand","year":"1993","journal-title":"Br Heart J"},{"key":"10.1053\/j.ajkd.2014.12.016_bib76","doi-asserted-by":"crossref","first-page":"365301","DOI":"10.4061\/2011\/365301","article-title":"Correction of iron deficiency in the cardiorenal syndrome","volume":"2011","author":"Silverberg","year":"2011","journal-title":"Int J Nephrol"},{"issue":"3","key":"10.1053\/j.ajkd.2014.12.016_bib77","doi-asserted-by":"crossref","first-page":"336","DOI":"10.4244\/V5I3A53","article-title":"Serum catalytic iron as a novel biomarker of vascular injury in acute coronary syndromes","volume":"5","author":"Lele","year":"2009","journal-title":"Eurointervention"},{"issue":"1","key":"10.1053\/j.ajkd.2014.12.016_bib78","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000346815","article-title":"Urine catalytic iron and neutrophil gelatinase-associated lipocalin as companion early markers of acute kidney injury after cardiac surgery: a prospective pilot study","volume":"3","author":"Akrawinthawong","year":"2013","journal-title":"Cardiorenal Med"},{"issue":"suppl 1","key":"10.1053\/j.ajkd.2014.12.016_bib79","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1046\/j.1365-2362.2002.0320s1036.x","article-title":"Nontransferrin-bound iron in the plasma of haemodialysis patients after intravenous iron saccharate infusion","volume":"32","author":"Kooistra","year":"2002","journal-title":"Eur J Clin Invest"},{"key":"10.1053\/j.ajkd.2014.12.016_bib80","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1755-8794-2-2","article-title":"Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases","volume":"2","author":"Kell","year":"2009","journal-title":"BMC Med Genomics"},{"issue":"2","key":"10.1053\/j.ajkd.2014.12.016_bib81","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.resp.2013.01.003","article-title":"Epo deficiency alters cardiac adaptation to chronic hypoxia","volume":"186","author":"El Hasnaoui-Saadani","year":"2013","journal-title":"Respir Physiol Neurobiol"},{"issue":"9","key":"10.1053\/j.ajkd.2014.12.016_bib82","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1096\/fj.03-1289fje","article-title":"Erythropoietin receptor expression in adult rat cardiomyocytes is associated with an acute cardioprotective effect for recombinant erythropoietin during ischemia-reperfusion injury","volume":"18","author":"Wright","year":"2004","journal-title":"FASEB J"},{"issue":"2","key":"10.1053\/j.ajkd.2014.12.016_bib83","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1523-1755.2005.00458.x","article-title":"Effects of erythropoietin on left ventricular hypertrophy in adults with severe chronic renal failure and hemoglobin\u00a0<10 g\/dL","volume":"68","author":"Ayus","year":"2005","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ajkd.2014.12.016_bib84","first-page":"1","article-title":"Regression of left ventricular hypertrophy in dialysis patients following correction of anemia with recombinant human erythropoietin","volume":"6","author":"Silberberg","year":"1990","journal-title":"Can J Cardiol"},{"issue":"2","key":"10.1053\/j.ajkd.2014.12.016_bib85","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0272-6386(00)70334-9","article-title":"Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure","volume":"35","author":"Hayashi","year":"2000","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.ajkd.2014.12.016_bib86","doi-asserted-by":"crossref","first-page":"755","DOI":"10.2215\/CJN.02730608","article-title":"Erythropoietin therapy and left ventricular mass index in CKD and ESRD patients: a meta-analysis","volume":"4","author":"Parfrey","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2014.12.016_bib87","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1159\/000351175","article-title":"Cardiovascular toxicity of epoetin-alfa in patients with chronic kidney disease","volume":"37","author":"McCullough","year":"2013","journal-title":"Am J Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2014.12.016_bib88","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.ahj.2012.08.019","article-title":"Effect of admission oral diuretic dose on response to continuous versus bolus intravenous diuretics in acute heart failure: an analysis from diuretic optimization strategies in acute heart failure","volume":"164","author":"Shah","year":"2012","journal-title":"Am Heart J"},{"issue":"2","key":"10.1053\/j.ajkd.2014.12.016_bib89","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1161\/CIRCHEARTFAILURE.112.969246","article-title":"Markers of decongestion, dyspnea relief, and clinical outcomes among patients hospitalized with acute heart failure","volume":"6","author":"Kociol","year":"2013","journal-title":"Circ Heart Fail"},{"issue":"8","key":"10.1053\/j.ajkd.2014.12.016_bib90","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0002-9149(96)00465-1","article-title":"Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the Randomized Aldactone Evaluation Study [RALES])","volume":"78","year":"1996","journal-title":"Am J Cardiol"},{"issue":"10","key":"10.1053\/j.ajkd.2014.12.016_bib91","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.ajkd.2014.12.016_bib92","first-page":"CD007004","article-title":"Aldosterone antagonists for preventing the progression of chronic kidney disease","volume":"3","author":"Navaneethan","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"10.1053\/j.ajkd.2014.12.016_bib93","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1161\/01.CIR.100.12.1311","article-title":"Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction","volume":"100","author":"Cooper","year":"1999","journal-title":"Circulation"},{"issue":"1","key":"10.1053\/j.ajkd.2014.12.016_bib94","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1523-1755.2002.00434.x","article-title":"Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients","volume":"62","author":"Chertow","year":"2002","journal-title":"Kidney Int"},{"issue":"6","key":"10.1053\/j.ajkd.2014.12.016_bib95","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1053\/j.ajkd.2008.02.298","article-title":"A\u00a01-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with\u00a0comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study","volume":"51","author":"Qunibi","year":"2008","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.ajkd.2014.12.016_bib96","doi-asserted-by":"crossref","first-page":"c273","DOI":"10.1159\/000170783","article-title":"Phosphate binder impact on bone remodeling and coronary calcification\u2014results from the BRiC study","volume":"110","author":"Barreto","year":"2008","journal-title":"Nephron Clin Pract"},{"issue":"3","key":"10.1053\/j.ajkd.2014.12.016_bib97","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1053\/j.ajkd.2007.12.002","article-title":"A\u00a0comparison of sevelamer and calcium-based phosphate binders on mortality, hospitalization, and morbidity in hemodialysis: a secondary analysis of the Dialysis Clinical Outcomes Revisited (DCOR) randomized trial using claims data","volume":"51","author":"St Peter","year":"2008","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1053\/j.ajkd.2014.12.016_bib98","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.ahj.2012.09.018","article-title":"Vitamin D reduces left atrial volume in patients with left ventricular hypertrophy and chronic kidney disease","volume":"164","author":"Tamez","year":"2012","journal-title":"Am Heart J"},{"issue":"7","key":"10.1053\/j.ajkd.2014.12.016_bib99","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2012.120","article-title":"Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial","volume":"307","author":"Thadhani","year":"2012","journal-title":"JAMA"},{"issue":"1","key":"10.1053\/j.ajkd.2014.12.016_bib100","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1681\/ASN.2013010103","article-title":"Effect of paricalcitol on left ventricular mass and function in CKD\u2014the OPERA trial","volume":"25","author":"Wang","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"26","key":"10.1053\/j.ajkd.2014.12.016_bib101","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMoa1205624","article-title":"Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis","volume":"367","author":"Chertow","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"25","key":"10.1053\/j.ajkd.2014.12.016_bib102","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.ajkd.2014.12.016_bib103","unstructured":"Ponikowski P, van Veldhuisen DJ, Comin-Colet J, et al. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency [published online ahead of print August 31, 2014]. Eur\u00a0Heart J. http:\/\/dx.doi.org.ezp-prod1.hul.harvard.edu\/10.1093\/eurheartj\/ehu385."},{"issue":"21","key":"10.1053\/j.ajkd.2014.12.016_bib104","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1056\/NEJMoa0907845","article-title":"A\u00a0trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease","volume":"361","author":"Pfeffer","year":"2009","journal-title":"N\u00a0Engl J Med"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638615000840?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638615000840?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T02:32:58Z","timestamp":1759458778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638615000840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":104,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0272638615000840"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2014.12.016","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiorenal Syndrome and the Role of the Bone-Mineral Axis\u00a0and\u00a0Anemia","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2014.12.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}